Cognitive Remediation in Bipolar Read the CRiB2 protocol for a randomised controlled trial assessing the efficacy and mechanisms of cognitive remediation therapy published in #BMCPsychiatry BMC Series KCL CfAD #ISRCTN: isrctn.com/ISRCTN10362331 bmcpsychiatry.biomedcentral.com/articles/10.11…

This session was fantastic and was presented by Dr Rebecca Strawbridge Becci Strawbridge It was also personally interesting and important to me as it covered the therapy I deliver (Cognitive Remediation Therapy) at KCL CfAD #ISAD2023

Michael Kalfas & #BeyonTheRoom correspondent Rosie from KCL CfAD will now tell us about the “Subjective cognitive impairment in #bipolardisorder: predictors of discrepancy with objective cognition and association with functioning” #ISAD2023 THREAD 👇

Anna Tröger (a KCL CfAD PhD student) presents her poster, a meta-analysis and meta-regression reporting that: Baseline depression severity does not moderate the effects of psychotherapy compared with pharmacotherapy for depression. #ISAD2023

KCL CfAD CRiB2 researchers Michael Kalfas and Rosie presented preliminary findings regarding the discrepancy between subjective and objective reports of cognitive performance at #ISAD2023 The implications for cognitive remediation therapy were discussed

Jury remains out on antidepressant-induced mania, despite findings of Danish trial emulation nationalelfservice.net/?p=203123 Michael Kalfas and Paul Leeks summarise a recent Danish study that assesses the risk of antidepressant-induced mania in patients with bipolar depression.

AURA.

Published today in Lancet Psychiatry, after 7 years of hard labour... the first long-term head-to-head comparison of two augmentation treatments in treatment resistant depression. Clinical and cost-effectiveness of lithium versus quetiapine augmentat... sciencedirect.com/science/articl…

expert reaction to systematic review and meta-analysis on antidepressant withdrawal symptoms sciencemediacentre.org/expert-reactio…

Our new meta-analysis exploring the incidence and nature of antidepressant discontinuation symptoms, published in JAMA Psychiatry

Congratulations Sameer Jauhar et al I look forward to finally reading this paper I’ve heard so much about but sorry it has led to such vitriol and abuse on here 😔

Our new review on antidepressant withdrawal led by Michael Kalfas Sameer Jauhar Estimates similar to ANTLER trial where ~75% had been on antidepressants for >3 years & were followed for 12 months Variability around this estimate - 3% of people experience severe withdrawal

The largest review of its kind on #antidepressant withdrawal symptoms published results yesterday. Researchers say it provides much needed, clearer guidance for clinicians, patients and policymakers. Click the link to read more👇 #IoPPNNews bit.ly/4lEx0Lo

Antidepressant withdrawal symptoms may be less common than previously thought, a 'gold standard' data review has found. Imperial Department of Brain Sciences, King's College London and @UCL researchers reviewed 50 studies with more than 17,000 participants 🔽 imperial.ac.uk/news/266013/re…

Most viewed this week from JAMA Psychiatry: Systematic review and meta-analysis: Stopping antidepressants leads to slight symptom increases compared to placebo, but these symptoms are not clinically significant and do not include mood changes. ja.ma/3IGmK72

"I don't like being famous, I just like basketball." Giannis with a GOAT post-game speech. 🥹❤️ #EuroBasket | #MakeYourMark

How it started vs. how it's going. (via kostas__ante37/IG)